TY - JOUR
T1 - Antiviral therapy for COVID-2019
AU - Hidayati, Hanik Badriyah
AU - Octavia, Evi
AU - Srisetyaningrum, Cempaka Thursina
N1 - Publisher Copyright:
© 2021 Faculty of Anaesthesia, Pain and Intensive Care, AFMS. All rights reserved.
PY - 2021/6/1
Y1 - 2021/6/1
N2 - The whole world is experiencing a global pandemic caused by Coronavirus disease 2019. As the pandemic progresses, there has been much research on antiviral drugs, such as hydroxychloroquin, chloroquine, remdesivir, lopinavir-ritonavir, favipiravir, oseltamivir, and umifenovir. Specific antiviral drugs proven to be effective against SARS-CoV-2 have not been found and approved for the medication of COVID-19. Currently, case detection, infection control, monitoring, prevention, and supportive care are the means focused on the treatment of COVID-19. A large scale research is currently underway to analyze safety and efficacy of antiviral drugs, while trials of the SAR-CoV-2 vaccine are rapidly expanding. This mini review briefly introduces the current antiviral therapy for COVID-19.
AB - The whole world is experiencing a global pandemic caused by Coronavirus disease 2019. As the pandemic progresses, there has been much research on antiviral drugs, such as hydroxychloroquin, chloroquine, remdesivir, lopinavir-ritonavir, favipiravir, oseltamivir, and umifenovir. Specific antiviral drugs proven to be effective against SARS-CoV-2 have not been found and approved for the medication of COVID-19. Currently, case detection, infection control, monitoring, prevention, and supportive care are the means focused on the treatment of COVID-19. A large scale research is currently underway to analyze safety and efficacy of antiviral drugs, while trials of the SAR-CoV-2 vaccine are rapidly expanding. This mini review briefly introduces the current antiviral therapy for COVID-19.
KW - COVID-19
KW - Drugs
KW - Key word: Antiviral therapy
UR - http://www.scopus.com/inward/record.url?scp=85108914786&partnerID=8YFLogxK
U2 - 10.35975/apic.v25i3.1522
DO - 10.35975/apic.v25i3.1522
M3 - Review article
AN - SCOPUS:85108914786
SN - 1607-8322
VL - 25
SP - 387
EP - 392
JO - Anaesthesia, Pain and Intensive Care
JF - Anaesthesia, Pain and Intensive Care
IS - 3
ER -